Abstract
Lipids, one of the major natural products, usually have high biocompatibility and low toxicity. Due to their proper physicochemical properties, they are the most commonly used materials for building modern drug delivery systems, especially nanocarriers. However, to impart new functions or to satisfy special requirements, the lipids can be modified or synthesized. Using lipids or lipid derivatives, various lipid-based drug or gene delivery systems have been developed and show potential in pre-clinical and clinical applications. In this article, the most commonly used lipids are discussed in terms of their properties and functions as drug carrier components, their chemical modifications, the formulation or composition of lipid-based nanocarriers, and their biomedical applications. This article provides a critical view and possible future directions of lipid-based drug delivery strategies.
Keywords: Drug delivery, gene delivery, lipids, lipid conjugate, lipid derivatives, nanocarrier, natural product.
Current Drug Targets
Title:Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems
Volume: 15 Issue: 5
Author(s): Ying Tu and Lin Zhu
Affiliation:
Keywords: Drug delivery, gene delivery, lipids, lipid conjugate, lipid derivatives, nanocarrier, natural product.
Abstract: Lipids, one of the major natural products, usually have high biocompatibility and low toxicity. Due to their proper physicochemical properties, they are the most commonly used materials for building modern drug delivery systems, especially nanocarriers. However, to impart new functions or to satisfy special requirements, the lipids can be modified or synthesized. Using lipids or lipid derivatives, various lipid-based drug or gene delivery systems have been developed and show potential in pre-clinical and clinical applications. In this article, the most commonly used lipids are discussed in terms of their properties and functions as drug carrier components, their chemical modifications, the formulation or composition of lipid-based nanocarriers, and their biomedical applications. This article provides a critical view and possible future directions of lipid-based drug delivery strategies.
Export Options
About this article
Cite this article as:
Tu Ying and Zhu Lin, Lipids and Their Derivatives: By-Products Used as Essential Building Blocks for Modern Drug Delivery Systems, Current Drug Targets 2014; 15 (5) . https://dx.doi.org/10.2174/1389450115666140306154120
DOI https://dx.doi.org/10.2174/1389450115666140306154120 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
New drug therapy for eye diseases
Eyesight is one of the most critical senses, accounting for over 80% of our perceptions. Our quality of life might be significantly affected by eye disease, including glaucoma, diabetic retinopathy, dry eye, etc. Although the development of microinvasive ocular surgery reduces surgical complications and improves overall outcomes, medication therapy is ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cell-Penetrating Peptide-Mediated Therapeutic Molecule Delivery into the Central Nervous System
Current Neuropharmacology Imaging of Spinal Bone Tumors: Principles and Practice
Current Medical Imaging Predictive and Prognostic Value of Ascitic Fluid Mannose Binding Lectin in Patients with Spontaneous Bacterial Peritonitis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Convection Enhanced Drug Delivery of Novel Therapeutic Agents to Malignant Brain Tumors
Current Drug Delivery Cytochromes P450 in Brain: Function and Significance
Current Drug Metabolism Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Immunosuppression in Liver Transplantation
Current Drug Targets A Novel Monocyte-based Pyrogen Test Based on the Mechanism of Human Fever Reaction
Current Pharmaceutical Analysis Tumor Necrosis Factor Inhibitors as Therapeutic Choice in Psoriasis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Pharmacological Targets for the Inhibition of Neurogenic Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Smart Drug-Delivery Systems for Cancer Nanotherapy
Current Drug Targets Novel Synthetic Compounds as Potential Anticryptococcal Agents
Current Organic Synthesis The Role of Glutamate and its Receptors in Migraine
CNS & Neurological Disorders - Drug Targets Aquaporin and Blood Brain Barrier
Current Neuropharmacology Syphilis and HIV Co-Infection: When is Lumbar Puncture Indicated?
Current HIV Research Neural Stem Cell Niches in Health and Diseases
Current Pharmaceutical Design Anti-Biofilm Strategies and the Need for Innovations in Wound Care
Recent Patents on Anti-Infective Drug Discovery Docking Studies for Multi-Target Drugs
Current Drug Targets A Critical Analysis of New Molecular Targets and Strategies for Drug Developments in Alzheimers Disease
Current Drug Targets Gene Cloning and Homology Modeling of the 3-Oxoacyl-ACP Synthase from Aeromonas hydrophila for Drug Discovery
Letters in Drug Design & Discovery